Search

everythinglearnresearchcommunity

for

Search:↓

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

Combining LFQS and IPL is more effective and faster for treating melasma than LFQS alone.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Androgen use may increase the risk of stroke, but more research is needed.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Vitiligo and alopecia areata may have similar causes despite their differences.

PCOS should be reclassified into two types based on hormone levels and symptoms.

The Tyrolean Iceman had mostly Anatolian farmer ancestry and traits like darker skin and a risk for certain health issues.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Schizophrenia risk genes may affect early brain development, contributing to the disease.

The risks of testosterone implants in women outweigh the benefits.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Virus infection risk is linked to heat tolerance and size, but decreases with high humidity and mutation rate.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hydroquinone may harm skin, while kojic acid and aloe vera could reduce its negative effects.

Mutation in hairless gene may increase hair loss risk.

Mutation in hairless gene may increase hair loss risk.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Smoking doubles the risk of blindness, and physical exercise helps dyslexic children read better.